查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1819875

COVID-19 診斷市場報告，按產品類型、樣本類型、測試類型（分子測試、抗原測試、抗體測試等）、模式（即時診斷、非即時診斷）、最終用途和地區分類，2025 年至 2033 年

COVID-19 Diagnostics Market Report by Product Type, Sample Type, Test Type (Molecular Testing, Antigen-based Testing, Antibody Testing, and Others), Mode (Point-of-Care, Non-Point-of-Care ), End Use, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2024 年全球 COVID-19 診斷市場規模達 583 億美元。展望未來， IMARC Group預計到 2033 年市場規模將達到 290 億美元。

COVID-19 診斷是指為檢測個體是否有病毒感染而進行的臨床檢測。 COVID-19 是由新發現的人畜共通冠狀病毒引起的傳染病。一些常見症狀包括發燒、疲勞、乾咳、呼吸急促、喉嚨痛和身體疼痛。病毒感染通常透過逆轉錄聚合酶鏈反應 (RT-PCR)、抗原和抗體檢測來診斷。這些檢測使用試劑和試劑盒從鼻咽拭子 (NP)、口咽拭子 (OP) 和鼻腔拭子、人體唾液或血液中取得樣本。它們廣泛應用於醫院、實驗室、診所、研究機構和診斷中心。

新冠病毒疫情的突然爆發以及全球新冠肺炎病例數量的驚人成長，是市場成長前景樂觀的關鍵因素之一。每日新增病例數的持續成長促使診斷檢測被廣泛採用，以便快速、全面地進行檢測，從而為患者提供早期治療。同時，對大規模檢測和分子診斷的需求日益成長，也促進了市場的成長。此外，各種產品創新，例如用於家庭檢測的新型抗體和血清學檢測試劑盒的推出，也成為其他成長的推動因素。與傳統檢測試劑盒相比，這些試劑盒耗時更少，並且可以與基於軟體的程式整合以獲得準確的結果。其他因素，包括政府為防止新冠肺炎感染進一步蔓延而實施的優惠政策，以及醫療保健基礎設施的顯著改善（尤其是在發展中經濟體），預計將推動市場成長。

本報告回答的關鍵問題

  • 2024年全球COVID-19診斷市場規模？ COVID-19對全球COVID-19診斷市場有何影響？
  • 推動全球 COVID-19 診斷市場發展的關鍵因素有哪些？
  • 根據產品類型，全球 COVID-19 診斷市場是如何分佈的？
  • 根據樣本類型，全球 COVID-19 診斷市場如何分佈？
  • 根據測試類型，全球 COVID-19 診斷市場如何分佈？
  • 根據模式，全球 COVID-19 診斷市場的分佈如何？
  • 根據最終用途，全球 COVID-19 診斷市場的分佈如何？
  • 全球 COVID-19 診斷市場的主要地區有哪些？
  • 全球 COVID-19 診斷市場的主要參與者/公司有哪些？

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 二手資料
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

第5章：全球 COVID-19 診斷市場

  • 市場概況
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場區隔：依產品類型

  • 試劑和試劑盒
  • 儀器
  • 其他

第7章：市場區隔：依樣本類型

  • 鼻咽拭子
  • 口咽拭子
  • 鼻拭子
  • 血
  • 其他

第 8 章：市場區隔：按測試類型

  • 分子（RT-PCR）檢測
  • 基於抗原的檢測
  • 抗體（血清學）檢測
  • 其他

第9章：市場細分：依模式

  • 照護端（PoC）
  • 非照護端（Non-PoC）

第 10 章：市場區隔：最終用途別

  • 實驗室
  • 醫院
  • 診斷中心和診所
  • 其他

第 11 章：市場區隔：按地區

  • 北美洲
    • 美國
      • 市場趨勢及預測
    • 加拿大
      • 市場趨勢及預測
  • 亞太
    • 中國
      • 市場趨勢及預測
    • 日本
      • 市場趨勢及預測
    • 印度
      • 市場趨勢及預測
    • 韓國
      • 市場趨勢及預測
    • 澳洲
      • 市場趨勢及預測
    • 印尼
      • 市場趨勢及預測
    • 其他
      • 市場趨勢及預測
  • 歐洲
    • 德國
      • 市場趨勢及預測
    • 法國
      • 市場趨勢及預測
    • 英國
      • 市場趨勢及預測
    • 義大利
      • 市場趨勢及預測
    • 西班牙
      • 市場趨勢及預測
    • 俄羅斯
      • 市場趨勢及預測
    • 其他
      • 市場趨勢及預測
  • 拉丁美洲
    • 巴西
      • 市場趨勢及預測
    • 墨西哥
      • 市場趨勢及預測
    • 其他
      • 市場趨勢及預測
  • 中東和非洲
    • 市場趨勢及預測
    • 市場區隔：依國家

第 12 章：SWOT 分析

第 13 章：價值鏈分析

第 14 章：波特五力分析

第 15 章：價格分析

第 16 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Becton Dickinson and Company
    • bioMerieux SA
    • Bio-Rad Laboratories
    • Danaher Corporation
    • F. Hoffman-La Roche Ltd. (Roche Holding AG)
    • Luminex Corporation
    • PerkinElmer Inc.
    • Quest Diagnostics Incorporated
    • Robert Bosch GmbH
    • Seegene Inc.
    • Siemens Aktiengesellschaft
    • Thermo Fisher Scientific Inc.
Product Code: SR112025A3552

The global COVID-19 diagnostics market size reached USD 58.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 29.0 Billion by 2033.

COVID-19 diagnostics refer to the clinical tests conducted to detect the presence of the viral infection among individuals. COVID-19 is an infectious disease caused by the newly discovered zoonotic coronavirus. Some common symptoms include fever, fatigue, dry cough, shortness of breath, sore throat and body aches. The viral infection is usually diagnosed through reverse transcriptase-polymerase chain reaction (RT- PCR), antigen-based and antibody testing. These tests use reagents and kits to obtain the sample from nasopharyngeal (NP), oropharyngeal (OP) and nasal swabs, human saliva or blood. They are widely used in hospitals, laboratories, clinics, research institutes and diagnostic centers.

The sudden outbreak of coronavirus disease and an alarming increase in the number of COVID-19 cases across the globe are among the key factors creating a positive outlook for the market growth. The continuous rise in the number of daily cases has led to the widespread adoption of diagnostic tests for rapid and comprehensive testing to provide early treatment to the patients. In line with this, the increasing demand for mass testing and molecular diagnostics is contributing to the market growth. Additionally, various product innovations, such as the launch of novel antibody and serology test kits for home-testing, are acting as other growth-inducing factors. In comparison to the traditionally used testing kits, these variants are less time-consuming and can be integrated with software-based programs for accurate results. Other factors, including the implementation of favorable government polices to prevent the further spread of COVID-19 infection, along with significant improvements in the healthcare infrastructure, especially in the developing economies, are anticipated to drive the market growth.

Key Market Segmentation:

Breakup by Product Type:

  • Reagents and Kits
  • Instruments
  • Others

Breakup by Sample Type:

  • Nasopharyngeal Swabs
  • Oropharyngeal Swabs
  • Nasal Swabs
  • Blood
  • Others

Breakup by Test Type:

  • Molecular (RT-PCR) Testing
  • Antigen-based Testing
  • Antibody (Serology) Testing
  • Others

Breakup by Mode:

  • Point-of-Care (PoC)
  • Non-Point-of-Care (Non-PoC)

Breakup by End Use:

  • Laboratories
  • Hospitals
  • Diagnostic Centers and Clinics
  • Others

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories, Danaher Corporation, F. Hoffman-La Roche Ltd. (Roche Holding AG), Luminex Corporation, PerkinElmer Inc., Quest Diagnostics Incorporated, Robert Bosch GmbH, Seegene Inc., Siemens Aktiengesellschaft and Thermo Fisher Scientific Inc.

Key Questions Answered in This Report

  • 1.What was the size of the global COVID-19 diagnostics market in 2024?
  • 2.What has been the impact of COVID-19 on the global COVID-19 diagnostics market?
  • 3.What are the key factors driving the global COVID-19 diagnostics market?
  • 4.What is the breakup of the global COVID-19 diagnostics market based on the product type?
  • 5.What is the breakup of the global COVID-19 diagnostics market based on the sample type?
  • 6.What is the breakup of the global COVID-19 diagnostics market based on the test type?
  • 7.What is the breakup of the global COVID-19 diagnostics market based on the mode?
  • 8.What is the breakup of the global COVID-19 diagnostics market based on the end use?
  • 9.What are the key regions in the global COVID-19 diagnostics market?
  • 10.Who are the key players/companies in the global COVID-19 diagnostics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global COVID-19 Diagnostics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Reagents and Kits
    • 6.1.1 Market Trends and Forecast
  • 6.2 Instruments
    • 6.2.1 Market Trends and Forecast
  • 6.3 Others
    • 6.3.1 Market Trends and Forecast

7 Market Breakup by Sample Type

  • 7.1 Nasopharyngeal Swabs
    • 7.1.1 Market Trends and Forecast
  • 7.2 Oropharyngeal Swabs
    • 7.2.1 Market Trends and Forecast
  • 7.3 Nasal Swabs
    • 7.3.1 Market Trends and Forecast
  • 7.4 Blood
    • 7.4.1 Market Trends and Forecast
  • 7.5 Others
    • 7.5.1 Market Trends and Forecast

8 Market Breakup by Test Type

  • 8.1 Molecular (RT-PCR) Testing
    • 8.1.1 Market Trends and Forecast
  • 8.2 Antigen-based Testing
    • 8.2.1 Market Trends and Forecast
  • 8.3 Antibody (Serology) Testing
    • 8.3.1 Market Trends and Forecast
  • 8.4 Others
    • 8.4.1 Market Trends and Forecast

9 Market Breakup by Mode

  • 9.1 Point-of-Care (PoC)
    • 9.1.1 Market Trends and Forecast
  • 9.2 Non-Point-of-Care (Non-PoC)
    • 9.2.1 Market Trends and Forecast

10 Market Breakup by End Use

  • 10.1 Laboratories
    • 10.1.1 Market Trends and Forecast
  • 10.2 Hospitals
    • 10.2.1 Market Trends and Forecast
  • 10.3 Diagnostic Centers and Clinics
    • 10.3.1 Market Trends and Forecast
  • 10.4 Others
    • 10.4.1 Market Trends and Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends and Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends and Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends and Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends and Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends and Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends and Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends and Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends and Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends and Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends and Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends and Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends and Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends and Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends and Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends and Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends and Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends and Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends and Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends and Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends and Forecast
    • 11.5.2 Market Breakup by Country

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Abbott Laboratories
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
      • 16.3.1.4 SWOT Analysis
    • 16.3.2 Becton Dickinson and Company
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 bioMerieux SA
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
      • 16.3.3.3 Financials
      • 16.3.3.4 SWOT Analysis
    • 16.3.4 Bio-Rad Laboratories
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
      • 16.3.4.3 Financials
      • 16.3.4.4 SWOT Analysis
    • 16.3.5 Danaher Corporation
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
      • 16.3.5.3 Financials
      • 16.3.5.4 SWOT Analysis
    • 16.3.6 F. Hoffman-La Roche Ltd. (Roche Holding AG)
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 Financials
    • 16.3.7 Luminex Corporation
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
      • 16.3.7.4 SWOT Analysis
    • 16.3.8 PerkinElmer Inc.
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Quest Diagnostics Incorporated
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
      • 16.3.9.4 SWOT Analysis
    • 16.3.10 Robert Bosch GmbH
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Seegene Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
    • 16.3.12 Siemens Aktiengesellschaft
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio
      • 16.3.12.3 Financials
      • 16.3.12.4 SWOT Analysis
    • 16.3.13 Thermo Fisher Scientific Inc.
      • 16.3.13.1 Company Overview
      • 16.3.13.2 Product Portfolio
      • 16.3.13.3 Financials
      • 16.3.13.4 SWOT Analysis

List of Figures

  • Figure 1: Global: COVID-19 Diagnostics Market: Major Drivers and Challenges
  • Figure 2: Global: COVID-19 Diagnostics Market: Sales Value (in Billion USD), 2025-2033
  • Figure 3: Global: COVID-19 Diagnostics Market: Breakup by Product Type (in %), 2024
  • Figure 4: Global: COVID-19 Diagnostics Market: Breakup by Sample Type (in %), 2024
  • Figure 5: Global: COVID-19 Diagnostics Market: Breakup by Test Type (in %), 2024
  • Figure 6: Global: COVID-19 Diagnostics Market: Breakup by Mode (in %), 2024
  • Figure 7: Global: COVID-19 Diagnostics Market: Breakup by End Use (in %), 2024
  • Figure 8: Global: COVID-19 Diagnostics Market: Breakup by Region (in %), 2024
  • Figure 9: Global: COVID-19 Diagnostics (Reagents and Kits) Market: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: COVID-19 Diagnostics (Instruments) Market: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: COVID-19 Diagnostics (Other Product Types) Market: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: COVID-19 Diagnostics (Nasopharyngeal Swabs) Market: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: COVID-19 Diagnostics (Oropharyngeal Swabs) Market: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: COVID-19 Diagnostics (Nasal Swabs) Market: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: COVID-19 Diagnostics (Blood) Market: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: COVID-19 Diagnostics (Other Sample Types) Market: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: COVID-19 Diagnostics (Molecular/RT-PCR Testing) Market: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: COVID-19 Diagnostics (Antigen-based Testing) Market: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: COVID-19 Diagnostics (Antibody-Testing- Serology) Market: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: COVID-19 Diagnostics (Other Test Types) Market: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: COVID-19 Diagnostics (Point-of-Care - PoC) Market: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: COVID-19 Diagnostics (Non-Point-of-Care - Non-PoC) Market: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: COVID-19 Diagnostics (Laboratories) Market: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: COVID-19 Diagnostics (Hospitals) Market: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: COVID-19 Diagnostics (Diagnostic Centers and Clinics) Market: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: COVID-19 Diagnostics (Other End Uses) Market: Sales Value (in Million USD), 2025-2033
  • Figure 27: North America: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 28: United States: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 29: Canada: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 30: Asia-Pacific: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 31: China: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 32: Japan: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 33: India: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 34: South Korea: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 35: Australia: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 36: Indonesia: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 37: Others: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 38: Europe: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 39: Germany: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 40: France: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 41: United Kingdom: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 42: Italy: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 43: Spain: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 44: Russia: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 45: Others: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 46: Latin America: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 47: Brazil: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 48: Mexico: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 49: Others: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 50: Middle East and Africa: COVID-19 Diagnostics Market: Sales Value (in Million USD), 2025-2033
  • Figure 51: Middle East and Africa: COVID-19 Diagnostics Market: Breakup by Country (in %), 2024
  • Figure 52: Global: COVID-19 Diagnostics Industry: SWOT Analysis
  • Figure 53: Global: COVID-19 Diagnostics Industry: Value Chain Analysis
  • Figure 54: Global: COVID-19 Diagnostics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: COVID-19 Diagnostics Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: COVID-19 Diagnostics Market Forecast: Breakup by Product Type (in Million USD), 2025-2033
  • Table 3: Global: COVID-19 Diagnostics Market Forecast: Breakup by Sample Type (in Million USD), 2025-2033
  • Table 4: Global: COVID-19 Diagnostics Market Forecast: Breakup by Test Type (in Million USD), 2025-2033
  • Table 5: Global: COVID-19 Diagnostics Market Forecast: Breakup by Mode (in Million USD), 2025-2033
  • Table 6: Global: COVID-19 Diagnostics Market Forecast: Breakup by End Use (in Million USD), 2025-2033
  • Table 7: Global: COVID-19 Diagnostics Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: COVID-19 Diagnostics Market: Competitive Structure
  • Table 9: Global: COVID-19 Diagnostics Market: Key Players